Test Price
2,800 AED✅ Home Collection Available
DCDC2 Gene Nephronophthisis Type 19 Genetic Test in UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Platform.
Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection for whole blood, extracted DNA, or FTA card specimens. Available daily from 8 AM to 11 PM.
Clinical Guidance: Post-test telephonic clinical interpretation and genetic counseling coordination with a UAE-licensed Consultant Medical Geneticist.
Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
This precision genetic analysis is delivered in full compliance with UAE healthcare regulations, ensuring diagnostic accuracy and reliable clinical guidance under DHA supervision.
Test Overview & Methodology
The DCDC2 Gene Nephronophthisis Type 19 Genetic Test detects pathogenic mutations in the DCDC2 gene associated with autosomal recessive nephronophthisis type 19, a ciliopathy disorder that causes progressive renal cystic disease, liver fibrosis, and endocrine dysfunction. This next-generation sequencing assay enables precise diagnosis, family cascade screening, and informed clinical management for patients presenting with early-onset renal disease.
| Feature | DCDC2 NGS Panel | Closest Alternative |
|---|---|---|
| Precision | Full gene sequencing with copy number variant analysis (99.9% sensitivity) | Targeted mutation panel may miss rare variants |
| Method | Illumina NGS platform, ISO 9001:2015 validated | Sanger sequencing limited to known hot spots |
| Turnaround | 3 to 4 weeks with electronic report delivery | 5 to 8 weeks, paper report only |
| Clinical Support | UAE-licensed genetic counselor coordination and pedigree analysis | No post-test guidance provided |
Physician Insight & Safety Protocols
"As a Consultant Medical Geneticist, I emphasize that this genetic finding must be interpreted within the full clinical context. A positive DCDC2 mutation confirms the diagnosis, yet a negative result does not exclude nephronophthisis caused by other genes. Patients should continue all prescribed treatments and discuss any management changes with their nephrologist."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice for Medication Safety
⚠️ Medication Advisory
Do not discontinue prescribed medication without consulting your treating physician. Genetic results complement clinical care, they do not replace current therapeutic regimens.
Exclusion Criteria & Emergency Red Flags
- Patients unable to provide informed consent or with acute psychiatric instability.
- Uncontrolled bleeding disorder that contraindicates blood draw. Alternative DNA sources may be discussed with the genetic counselor.
- Pregnant individuals should discuss implications with a genetic counselor; the test may still be performed when medically indicated.
- Seek emergency care if you experience sudden severe flank pain, visible blood in urine, confusion, jaundice, or uncontrollable vomiting.
- Minors: Federal Decree-Law No. 4 of 2016 on Medical Liability requires legal guardian consent, and DHA-authorized genetic counseling is mandatory before proceeding.
Patient FAQ & Clinical Guidance
1. What clinical signs indicate the need for DCDC2 genetic testing?
Snippet-Killer Answer: This test is recommended when a patient presents with early-onset renal cystic disease, liver fibrosis, or endocrine abnormalities suggestive of nephronophthisis, particularly in consanguineous family settings common in the UAE population.
2. How accurate is the DCDC2 genetic test for diagnosing nephronophthisis type 19?
Snippet-Killer Answer: Our NGS test achieves 99.9% analytical sensitivity and specificity for single nucleotide variants and copy number alterations in the DCDC2 gene, using ISO 9001:2015 accredited sequencing chemistry on the Illumina platform.
3. Does health insurance in the UAE cover the DCDC2 genetic test?
Snippet-Killer Answer: Many UAE insurers cover genetic testing for nephronophthisis when medically justified. Contact our billing team via WhatsApp +971 54 548 8731 for a direct pre-authorization check under your specific policy.
4. What sample types are accepted for this genetic test?
Snippet-Killer Answer: We accept whole blood collected in EDTA tubes, extracted DNA samples, or dried blood spots on FTA cards. For home collection, our trained phlebotomist will collect whole blood using VIP mobile phlebotomy between 8 AM and 11 PM daily.
5. Is pre-test genetic counseling mandatory before proceeding?
Snippet-Killer Answer: Yes, a clinical history review and a dedicated genetic counseling session to construct a pedigree chart of family members potentially affected by DCDC2-related nephronophthisis are mandatory before sample collection. This ensures informed consent and appropriate test selection.
UAE Regulatory & Data Privacy Adherence
All genetic testing and data handling at DNA Labs UAE strictly comply with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, processing, and storage of personal and genetic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring secure digital health data exchange and tele-counseling practices.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – governing clinical consent protocols, patient safety, and professional accountability in genetic diagnostics.
Your genetic data is processed under ISO 9001:2015 certified protocols and stored on UAE-based secure servers. For data access requests or privacy concerns, contact our data protection officer.
Clinical & Logistical Metadata
| Test Name | DCDC2 Gene Nephronophthisis Type 19 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Whole blood (EDTA tube), extracted DNA, or dried blood spot (FTA card). VIP mobile phlebotomy available daily from 8 AM to 11 PM. |
| Methodology Used | Next-Generation Sequencing (NGS) on Illumina platform with full gene coverage and copy number variant analysis |
| ICD-10-CM Code | Q61.9 |
| LOINC Code | 101387-5 |
| DHA Facility License & Address | DHA Facility License Number: 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Corporate Lab: DNA Labs UAE. |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians